These 4 charts show the scale of Novo Nordisk’s woes
Novo Nordisk was the first company to make a GLP-1 drug for weight loss and became Europe’s most…
Trump, Eli Lilly, Novo Nordisk unveil deals to cut obesity drug prices
U.S. President Donald Trump attends an event to make an announcement from the Oval Office at the White…
Novo Nordisk CEO talks GLP-1 pill at JPMorgan conference
Novo Nordisk CEO Mike Doustdar shakes hands with President Donald Trump during an event to announce a deal…